Indication
Prophylaxis of influenza caused by A(H1N1)v 2009 virus. Celvapan should be used in accordance with official guidance.
Loading your page…
Loading your page…
Disease Outbreaks;Influenza, Human;Immunization
Marketing Authorisation Holder: Nanotherapeutics Bohumil, s.r.o.
EMA Authorisation: 04/03/2009
INN: influenza vaccine (H1N1)v (whole virion, Vero cell derived, inactivated)
AI Drug & Interaction Analysis
Free account required
Ask Osler about Celvapan: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.